Envestnet Asset Management Inc. Sells 5,988 Shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Envestnet Asset Management Inc. lowered its holdings in iShares US Pharmaceuticals ETF (NYSEARCA:IHEGet Rating) by 45.7% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,118 shares of the company’s stock after selling 5,988 shares during the period. Envestnet Asset Management Inc. owned approximately 0.30% of iShares US Pharmaceuticals ETF worth $1,364,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of IHE. Janney Montgomery Scott LLC lifted its holdings in shares of iShares US Pharmaceuticals ETF by 2.4% during the 2nd quarter. Janney Montgomery Scott LLC now owns 8,572 shares of the company’s stock worth $1,636,000 after acquiring an additional 201 shares during the period. Hallmark Capital Management Inc. bought a new stake in shares of iShares US Pharmaceuticals ETF during the 2nd quarter worth approximately $57,000. Vontobel Holding Ltd. lifted its holdings in shares of iShares US Pharmaceuticals ETF by 14.3% during the 2nd quarter. Vontobel Holding Ltd. now owns 2,000 shares of the company’s stock worth $383,000 after acquiring an additional 250 shares during the period. Venture Visionary Partners LLC bought a new stake in shares of iShares US Pharmaceuticals ETF during the 2nd quarter worth approximately $53,000. Finally, Institute for Wealth Management LLC. lifted its holdings in shares of iShares US Pharmaceuticals ETF by 18.0% during the 2nd quarter. Institute for Wealth Management LLC. now owns 2,832 shares of the company’s stock worth $543,000 after acquiring an additional 432 shares during the period.

iShares US Pharmaceuticals ETF Stock Up 0.2 %

Shares of iShares US Pharmaceuticals ETF stock opened at $181.71 on Tuesday. The company has a 50 day moving average of $175.77 and a 200-day moving average of $183.79. iShares US Pharmaceuticals ETF has a 1-year low of $166.99 and a 1-year high of $202.77.

iShares US Pharmaceuticals ETF Profile

(Get Rating)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

See Also

Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares US Pharmaceuticals ETF (NYSEARCA:IHEGet Rating).

Institutional Ownership by Quarter for iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Receive News & Ratings for iShares US Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares US Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.